✦ LIBER ✦

772 PUBLICATION Treatment of advanced gallbladder cancer with gemcitabine (gem) or gemcitabine-cisplatin (gem-cispl)

Book ID: 118623348
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 141 KB
Volume: 3
Category: Article
ISSN: 1359-6349
DOI: 10.1016/s1359-6349(05)81067-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

463 PUBLICATION Gemcitabine (GEM) plus o

463 PUBLICATION Gemcitabine (GEM) plus oxaliplatin (LOHP) as salvage treatment in anthracycline and taxane pretreated patients with advanced breast cancer (ABC)

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 277 KB

Concurrent cisplatin (CDDP), gemcitabine

Concurrent cisplatin (CDDP), gemcitabine (GEM) and external beam radiation therapy (EBRT) in the treatment of locally advanced pancreatic or periampullary cancer: tolerance and toxicity of treatment

✍ C.L Aitken; A Recht; K Stuart 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 27 KB

Randomized phase I study of weekly or ev

Randomized phase I study of weekly or every other week gemcitabine (GEM) plus cisplatin (CIS) in advanced non-small cell lung cancer (NSCLC)

✍ van Zandwijk, N; Schoemaker, N; Baas, P; Pluim, D; Malliepaard, M; Sparidans, R. 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 208 KB

32 Single-agent Gemzar® (Gemcitabine, GE

32 Single-agent Gemzar® (Gemcitabine, GEM) versus cisplatin plus etoposide (CE): A randomized phase II study in patients with locally advanced or metastatic non-small cell lung cancer (NSCLC)

✍ Manegold, Ch.; Stahel, R.; Mattson, K.; Ricci, S.; van Walree, N.C.; Bergman, B. 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 131 KB

Retrospective trial of concurrent gemcit

Retrospective trial of concurrent gemcitabine (GEM) or infusional 5-fluoruracil (5-FU), folinic acid (FA), interferon (IFN) treatment in patients with locally advanced or metastatic pancreatic adenocarcinoma

✍ Eickhoff, Axel S.; Jakobs, Ralf; Riemann, Juergen F. 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 183 KB

Randomized, Phase III Study of Gemcitabi

Randomized, Phase III Study of Gemcitabine or Erlotinib Maintenance Therapy Versus Observation, With Predefined Second-Line Treatment, After Cisplatin-Gemcitabine Induction Chemotherapy in Advanced Non-Small-Cell Lung Cancer

✍ Perol, M.; Chouaid, C.; Perol, D.; Barlesi, F.; Gervais, R.; Westeel, V.; Crequi 📂 Article 📅 2012 🏛 American Society of Clinical Oncology 🌐 English ⚖ 264 KB